- Home
- EEA vs PMVP Comparison
EEA vs PMVP Comparison
Compare EEA & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- PMVP
- Stock Information
- Founded
- EEA 1986
- PMVP 2013
- Country
- EEA Germany
- PMVP United States
- Employees
- EEA N/A
- PMVP N/A
- Industry
- EEA Trusts Except Educational Religious and Charitable
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- EEA Finance
- PMVP Health Care
- Exchange
- EEA Nasdaq
- PMVP Nasdaq
- Market Cap
- EEA 73.2M
- PMVP 74.7M
- IPO Year
- EEA N/A
- PMVP 2020
- Fundamental
- Price
- EEA $10.70
- PMVP $1.31
- Analyst Decision
- EEA
- PMVP Strong Buy
- Analyst Count
- EEA 0
- PMVP 1
- Target Price
- EEA N/A
- PMVP $5.00
- AVG Volume (30 Days)
- EEA 9.2K
- PMVP 715.8K
- Earning Date
- EEA 01-01-0001
- PMVP 11-07-2025
- Dividend Yield
- EEA 1.92%
- PMVP N/A
- EPS Growth
- EEA N/A
- PMVP N/A
- EPS
- EEA N/A
- PMVP N/A
- Revenue
- EEA N/A
- PMVP N/A
- Revenue This Year
- EEA N/A
- PMVP N/A
- Revenue Next Year
- EEA N/A
- PMVP N/A
- P/E Ratio
- EEA N/A
- PMVP N/A
- Revenue Growth
- EEA N/A
- PMVP N/A
- 52 Week Low
- EEA $7.45
- PMVP $0.81
- 52 Week High
- EEA $9.26
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- EEA 43.41
- PMVP 38.15
- Support Level
- EEA $10.57
- PMVP $1.38
- Resistance Level
- EEA $10.83
- PMVP $1.47
- Average True Range (ATR)
- EEA 0.15
- PMVP 0.09
- MACD
- EEA -0.02
- PMVP -0.03
- Stochastic Oscillator
- EEA 31.40
- PMVP 2.63
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.